Analysis of patients’ real medication experience and effect feedback of DaliRasen (Keweike)

Daridorexant is a new oral dual orexin receptor antagonist (Dual Orexin Receptor Antagonist, DORA), mainly used for the treatment of insomnia in adults. By inhibiting arousal-related neural pathways, it helps patients shorten the time it takes to fall asleep, extend the total sleep time, and improve the number of nighttime awakenings. Compared with traditional benzodiazepines, the mechanism of action of dalirazen is more targeted and the risk of dependence and tolerance is relatively low, which makes patients' experience safer and more comfortable in long-term use.

According to clinical observations and patient feedback, most patients can noticeably experience a shortened time to fall asleep and a reduced number of nighttime awakenings within the first 1 to 2 weeks after starting to take Dalilaysan. Some patients reported that the total sleep time was extended by about 1 to 2 hours on average, their mental state improved after waking up, and their sleepiness during the day was significantly reduced. Patients generally believe that the drug takes effect quickly and does not cause obvious residual sedation or "hangover" like traditional sleeping pills, which brings convenience to daily life and work.

Although it is generally well tolerated, some patients may still experience adverse reactions such as mild dizziness, dry mouth, or mild drowsiness in the early stages of use. These side effects usually gradually subside after a few days of continuous use and do not affect daily life. A small number of patients are more sensitive to drugs and may experience increased nighttime dreams or mild anxiety, but clinical studies show that the incidence of such phenomena is low and can be alleviated by adjusting the dosage or communicating with a doctor.

Patients who have been using DaliRazen for a long time generally report that the drug can continuously improve sleep quality, while also having a positive impact on daytime attention and mood state. Compared with traditional sleeping pills, patients are more likely to adhere to regular use and improve their lifestyle in conjunction with sleep hygiene. Overall, DaliRasen is not only recognized for its clinical efficacy, but also performs well in terms of patient experience, providing a new safe and effective treatment option for insomnia patients.

Reference materials:https://www.drugs.com/